Author： Nahon Stéphane Lahmek Pierre Durance Christelle Olympie Alain Lesgourgues Bruno Colombel Jean-Frédéric Gendre Jean-Pierre
Publisher： Blackwell Publishing
ISSN： 1078-0998
Source： Inflammatory Bowel Diseases, Vol.18, Iss.11, 2012-11, pp. : 2086-2091
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. :
Access to resources
Recommend
Inflammatory Bowel Disease in the Elderly
Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. :
Macrophages in Inflammatory Bowel Disease
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :